Your browser doesn't support javascript.
loading
Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies?
Park, JooYong; Choi, Ji-Yeob; Choi, Jaesung; Chung, Seokang; Song, Nan; Park, Sue K; Han, Wonshik; Noh, Dong-Young; Ahn, Sei-Hyun; Lee, Jong Won; Kim, Mi Kyung; Jee, Sun Ha; Wen, Wanqing; Bolla, Manjeet K; Wang, Qin; Dennis, Joe; Michailidou, Kyriaki; Shah, Mitul; Conroy, Don M; Harrington, Patricia A; Mayes, Rebecca; Czene, Kamila; Hall, Per; Teras, Lauren R; Patel, Alpa V; Couch, Fergus J; Olson, Janet E; Sawyer, Elinor J; Roylance, Rebecca; Bojesen, Stig E; Flyger, Henrik; Lambrechts, Diether; Baten, Adinda; Matsuo, Keitaro; Ito, Hidemi; Guénel, Pascal; Truong, Thérèse; Keeman, Renske; Schmidt, Marjanka K; Wu, Anna H; Tseng, Chiu-Chen; Cox, Angela; Cross, Simon S; Andrulis, Irene L; Hopper, John L; Southey, Melissa C; Wu, Pei-Ei; Shen, Chen-Yang; Fasching, Peter A; Ekici, Arif B.
Afiliação
  • Park J; Department of Biomedical Sciences, Seoul National University Graduate School, Seoul 03080, Korea.
  • Choi JY; BK21plus Biomedical Science Project, Seoul National University College of Medicine, Seoul 03080, Korea.
  • Choi J; Department of Biomedical Sciences, Seoul National University Graduate School, Seoul 03080, Korea.
  • Chung S; BK21plus Biomedical Science Project, Seoul National University College of Medicine, Seoul 03080, Korea.
  • Song N; Institute of Health Policy and Management, Seoul National University Medical Research Center, Seoul 03080, Korea.
  • Park SK; Cancer Research Institute, Seoul National University, Seoul 03080, Korea.
  • Han W; Institute of Health Policy and Management, Seoul National University Medical Research Center, Seoul 03080, Korea.
  • Noh DY; Department of Biomedical Sciences, Seoul National University Graduate School, Seoul 03080, Korea.
  • Ahn SH; College of Pharmacy, Chungbuk National University, Cheongju-si 28160, Korea.
  • Lee JW; Department of Biomedical Sciences, Seoul National University Graduate School, Seoul 03080, Korea.
  • Kim MK; Cancer Research Institute, Seoul National University, Seoul 03080, Korea.
  • Jee SH; Department of Preventive Medicine, Seoul National University College of Medicine, Seoul 03080, Korea.
  • Wen W; Cancer Research Institute, Seoul National University, Seoul 03080, Korea.
  • Bolla MK; Department of Surgery, Seoul National University College of Medicine, Seoul 03080, Korea.
  • Wang Q; Cancer Research Institute, Seoul National University, Seoul 03080, Korea.
  • Dennis J; Department of Surgery, Seoul National University College of Medicine, Seoul 03080, Korea.
  • Michailidou K; Department of Surgery, Medicine and ASAN Medical Center, University of Ulsan College, Seoul 05505, Korea.
  • Shah M; Department of Surgery, Medicine and ASAN Medical Center, University of Ulsan College, Seoul 05505, Korea.
  • Conroy DM; Division of Cancer Epidemiology and Management, National Cancer Center, Goyang-si 10408, Korea.
  • Harrington PA; Department of Epidemiology and Health Promotion, Institute for Health Promotion, Graduate School of Public Health, Yonsei University, Seoul 03722, Korea.
  • Mayes R; Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
  • Czene K; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB2 0SR, UK.
  • Hall P; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB2 0SR, UK.
  • Teras LR; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB2 0SR, UK.
  • Patel AV; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB2 0SR, UK.
  • Couch FJ; Biostatistics Unit, The Cyprus Institute of Neurology & Genetics, Nicosia 2371, Cyprus.
  • Olson JE; Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology & Genetics, Nicosia 23462, Cyprus.
  • Sawyer EJ; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK.
  • Roylance R; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK.
  • Bojesen SE; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK.
  • Flyger H; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK.
  • Lambrechts D; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 171 65 Stockholm, Sweden.
  • Baten A; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 171 65 Stockholm, Sweden.
  • Matsuo K; Department of Oncology, Södersjukhuset, 118 83 Stockholm, Sweden.
  • Ito H; Department of Population Science, American Cancer Society, Atlanta, GA 30303, USA.
  • Guénel P; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA.
  • Truong T; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA.
  • Keeman R; Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA.
  • Schmidt MK; School of Cancer & Pharmaceutical Sciences, Comprehensive Cancer Centre, Guy's Campus, King's College London, London SE1 9RT, UK.
  • Wu AH; Department of Oncology, UCLH Foundation Trust, London NW1 2PG, UK.
  • Tseng CC; Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, 2730 Herlev, Denmark.
  • Cox A; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, 2730 Herlev, Denmark.
  • Cross SS; Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
  • kConFab Investigators; Department of Breast Surgery, Herlev and Gentofte Hospital, Copenhagen University Hospital, 2730 Herlev, Denmark.
  • Andrulis IL; VIB Center for Cancer Biology, 3001 Leuve, Belgium.
  • Hopper JL; Laboratory for Translational Genetics, Department of Human Genetics, University of Leuven, 3000 Leuven, Belgium.
  • Southey MC; Department of Radiotherapy Oncology, KU Leuven-University of Leuven, University Hospitals Leuven, 3000 Leuven, Belgium.
  • Wu PE; Division of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya 464-8681, Japan.
  • Shen CY; Division of Cancer Epidemiology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
  • Fasching PA; Division of Cancer Epidemiology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
Cancers (Basel) ; 13(10)2021 May 14.
Article em En | MEDLINE | ID: mdl-34069208
ABSTRACT
In this study we aim to examine gene-environment interactions (GxEs) between genes involved with estrogen metabolism and environmental factors related to estrogen exposure. GxE analyses were conducted with 1970 Korean breast cancer cases and 2052 controls in the case-control study, the Seoul Breast Cancer Study (SEBCS). A total of 11,555 SNPs from the 137 candidate genes were included in the GxE analyses with eight established environmental factors. A replication test was conducted by using an independent population from the Breast Cancer Association Consortium (BCAC), with 62,485 Europeans and 9047 Asians. The GxE tests were performed by using two-step methods in GxEScan software. Two interactions were found in the SEBCS. The first interaction was shown between rs13035764 of NCOA1 and age at menarche in the GE|2df model (p-2df = 1.2 × 10-3). The age at menarche before 14 years old was associated with the high risk of breast cancer, and the risk was higher when subjects had homozygous minor allele G. The second GxE was shown between rs851998 near ESR1 and height in the GE|2df model (p-2df = 1.1 × 10-4). Height taller than 160 cm was associated with a high risk of breast cancer, and the risk increased when the minor allele was added. The findings were not replicated in the BCAC. These results would suggest specificity in Koreans for breast cancer risk.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article